• Home
  • The MMS Difference
    • About Us
    • Leadership
    • Certifications
  • Services
    • Regulatory Affairs and Operations
    • Data Management and Biostatistics
    • Regulatory and Medical Writing
    • Drug Safety and Pharmacovigilance
    • Compliance and Transparency
    • Data Sciences
  • Working with MMS
  • News and Media
  • MMS Blog
  • Careers
  • Contact Us
MMS
Why Should GDPR Matter to all Clinical Research Firms?

Why Should GDPR Matter to all Clinical Research Firms?

by curtis@digitalliance.com | May 24, 2018 | Blog

Why Should GDPR Matter to all Clinical Research Firms? by Barbara Rusin Since the beginning of 2018, there has been a growing interest from pharmaceutical and biotech firms in the United States regarding the basic tenets of the European Union’s (EU) new General Data...

Recent Posts

  • Pharmaceutical Industry News Roundup: November 2019
  • MMS HOLDINGS DOUBLES GROWTH IN SOUTH AFRICA REGION AMID BURGEONING PHARMACEUTICAL INDUSTRY LOCALLY
  • Pharmaceutical Industry News Roundup: October 2019
  • MMS HOLDINGS EXECUTIVE MICHELLE GAYARI JOINS ADVISORY BOARD OF INTERNATIONAL NONPROFIT THAT PROVIDES EDUCATIONAL PROGRAMS TO CHILDREN IN HOSPITALS
  • MMS HOLDINGS ANNOUNCES STATUS AS A FINALIST FOR BEST CONTRACT RESEARCH ORGANIZATION – SPECIALIST PROVIDERS IN SCRIP AWARDS DURING 10TH ANNUAL SCIENTIFIC SYMPOSIUM

Tags

ALZ awareness Alzheimers big data biosimilars biostatistics Clinical Development clinical research clinical study reports clinical trials clinical trial transparency Community Compliance CRO data management data privacy data science drug development EMA ENDALZ FDA Flint GDPR GXP auditing Health Analytics Collective Health Canada Lay summaries leadership medical writing NDA submission News opioids pharma pharmacovigilance PhUSE Policy 0070 quality control real world data regulatory operations REMS resourcing statistical programming suicidality transparency trial regulation Volunteering